CardiacSense, a medical device company, developed and is now selling FDA/CE cleared, wrist-based devices for continuous, accurate monitoring of human health. We enable optimal, rapid, access to actionable medical data, ensuring superior care.

Our system detects atrial fibrillation with 99% accuracy.

System includes a smart wristband that continuously monitors physiological measurements, transmitting medical data directly to patients’ smartphones. Data is analyzed using proprietary algorithms and AI and medical alerts are displayed on the wristband, to the nurse-station and emailed to patient/doctor.

We are expanding capabilities to measure absolute blood pressure and CHF deterioration attracting interest from multinational corporations.

Eitan Kyiet, Deputy CEO